Individuals who are interested in Botox typically show mild to moderate signs of aging. For example, patients may be experiencing static lines or wrinkles while at rest. During your first consultation your provider will discuss your concerns and goals as well as what to expect from consistent Botox treatments. Our providers will also discuss potential …
What To Expect From Your First Botox Consultation Read More »
Everyone has heard of Botox. But what is Botox 2.0? Botox Today Botox is a neurotoxin that lasts anywhere from three to five months. Botox has been around for many years and is very well known all over the world. Botox is used to help maintain a more youthful look when injected into facial muscles …
Allergan, the makers of Juvederm and Botox, have announced the acquisition of the Australian company, Elastagen, whose technology helps generate elastin in the skin. Elastin production in the skin can help minimize the appearance of scars, fine lines, stretch marks, wound repair, and is a key component in bright, youthful skin. Their “tropoelastin” is …
Allergan Acquires Elastagen to Help Create More Juvederm Products Read More »
Allergan announced the release of Juvederm Volite on January 27th, 2017 in Dublin, Ireland. Volite will be the first Juvederm product designed to improve skin quality. Other Juvederm products currently on the market are designed to fill wrinkles and restore lost volume in the face. This new product is an exciting addition as will only …
Juvederm Volite Launched in Europe by Allergan, Makers of Botox Read More »
Repost from Releasewire: As a top Preferred Provider with Allergan, Utah Facial Plastics is excited to be one of the first providers in Utah to offer an Juvederm Volbella to their repertoire of injectables. Salt Lake City, UT — (ReleaseWire) — 10/20/2016 —Juvederm Volbella XC is the newest member of the Juvederm family and is …
Utah Facial Plastics Is One of the First Providers to Offer Volbella in Utah Read More »
Okay, so they aren’t exactly new as these new hyaluronic acid fillers are currently being used in Europe but will be new to the US when FDA-approved. Clinical trials are currently taking place so we’re projecting they’ll be coming down the pipeline sometime in the near future. Both are hyaluronic acid fillers, like Juvederm and Voluma. …
Earlier this year, Allergan announced its acquisition of Anterios, Inc., a clinical stage biopharmaceutical company developing a topical Botox. With the acquisition comes the worldwide rights to ANT-1207, a topical formulation of botulinum toxin, which is being developed for the treatment of crow’s feet lines, acne, and hyperhidrosis (excessive sweating). “The acquisition of Anterios bolsters …
We’re excited to share that Khloe Kardashian is the new face of Kybella, the double-chin eliminating injectable from Allergan, the makers of Botox. Kybella has already gained a lot of attention as the first injectable to completely dissolve fat cells. But now with Khloe Kardashian supporting the treatment, interest is projected to sky-rocket. We all know …
Khloe Kardashian Sponsors Kybella, the “Double-Chin” Eliminator Read More »
It was reported this past week at the American Society for Dermatologic Surgery annual meeting that two phase 3 Kybella trials had reduction in submental fat and men were satisfied with the results. “The post-hoc analysis of the Refine-1 and Refine-2 trials showed that men got very good results, just like women did” said researcher …
Kybella Effective & Satisfactory in Trials with Men Read More »
A recent study was conducted on patient satisfaction following treatment Juvederm Voluma XC, a popular hyaluronic acid filler used to correct age-related midface volume deficit. The study was headed by Julius Few, MD at the University of Chicago Pritzker School of Medicine and involved 235 patients with moderate to severe age-related midface volume deficit (MVD). …
Draper Office
723 East 12200 South
Suite 200
Draper, UT 84020
Layton Office
2255 N 1700 W
Suite 205
Layton, UT 84041
CALL 801.776.2220
